Medicare Legislation Provides Incentives for ePrescribing


By Neil Versel, contributing editor

July 22, 2008 | Digital HealthCare & Productivity | The Medicare program could save as much as $156 million over the next five years from error avoidance and efficiency gains from a newly authorized electronic prescribing incentive program, federal officials say.

Legislation adopted last week to halt a scheduled 10.6 percent Medicare physician fee cut also includes financial incentives for ePrescribing. Eligible physicians and other authorized prescribers will receive 2 percent bonuses for writing electronic scripts for Medicare beneficiaries in 2009 and 2010. The bonus payments drop to 1 percent in 2011 and 2012 and to 0.5 percent in 2013.

But beginning in 2012, those who are not using ePrescribing technology for their Medicare patients will be subject to fee reductions. “We hope that we don’t get to the penalty, that we have ubiquitous ePrescribing by 2013,” American Academy of Family Physicians president James King said Monday in a conference call organized by the Department of Health and Human Services (HHS).

King said about 9 percent of AAFP members currently are ePrescribing, which means they are sending true electronic orders and messages to pharmacies, not computer-generated faxes.

Congress passed the Medicare bill over the veto of President Bush, who objected to reduced payments to third-party payers in the Medicare Advantage managed care program. The administration strongly supported the ePrescribing portion of the legislation, however.

“[ePrescribing] was not one of the reasons for the veto,” acting Centers for Medicare and Medicaid Services (CMS) administrator Kerry Weems said during the conference call with reporters.

“Advancing ePrescribing has been a top priority of this administration,” added HHS secretary Mike Leavitt.

Leavitt said HHS arrived at the $156 million figure by extrapolating to the Medicare population an Institute of Medicine (IOM) estimate that 1.5 million Americans are injured by prescribing errors each year and other studies suggesting that pharmacists make 150 million unnecessary phone calls annually to providers to clarify prescription orders. According to Leavitt, there are as many as 530,000 adverse drug events involving Medicare patients every year.

Weems said ePrescribing technology runs about $3,000 per prescriber in one-time acquisition costs, plus ongoing maintenance fees. He was not sure if the financial incentives would be enough to offset these expenses, as CMS still has to develop rules for administering the program. Weems said CMS will publish the incentive schedule as part of the agency’s 2009 fee revisions due out in the fall. The bill replaces the planned 10.6 percent fee cut with a 0.5 percent increase for 2008 and 1.1 percent rise next year.

The new bill also authorizes a case-by-case “hardship” exemption from the ePrescribing penalties. King says the hardship waiver “makes us a little more comfortable with the legislation.”

Leavitt said CMS will hold a conference this fall to help Medicare providers work through some of the logistical and technical issues related to the incentive program. He did not offer further details.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required. More job detail is found at: http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at [email protected]. Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008. DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here

Related Resources & Products

Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Antibiotic R&D;: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
Global Biotechnology Product Registration (1997)
Medical Device Development: A Regulatory Overview (2000)



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].